<DOC>
	<DOCNO>NCT01019629</DOCNO>
	<brief_summary>To determine patient deficiency alpha-galactosidase A at-risk cardiac complication commonly occur general population</brief_summary>
	<brief_title>Fabry Screening Study</brief_title>
	<detailed_description>Fabry disease X-linked deficiency alpha-galactosidase A result primarily accumulation globotriaosylceramide ( Gb3 ) virtually organs system . The main complication Fabry disease 20-fold increase risk ischemic stroke , cardiac disease include cardiomyopathy , atrio-ventricular conduction defect , wide variety arrhythmia , valvular dysfunction ( insufficiency stenosis ) cardiac vascular disease well progressive renal failure . Fabry disease easily diagnose patient routine EKGs , echocardiograms MRIs . Screening non-selected at-risk population patient ischemic stroke cardiac disease urinary Gb3 , alpha-galactosidase A activity GLA gene mutation enable identification patient previously undiagnosed Fabry disease among general population patient heart disease stroke</detailed_description>
	<mesh_term>Fabry Disease</mesh_term>
	<criteria>Any diagnosis heart disease . Male Female Able donate 12 cc whole blood 10 cc urine No diagnosis cardiac disease . Unable donate 12 cc whole blood and/or 10 cc urine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Fabry , Fabry Disease , Alpha-galactosidase A deficiency , GLA gene , mutation</keyword>
</DOC>